Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sandoz
With
Novartis Pharmaceuticals
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient with previously untreated advanced stage, CD20-positive FL
Patient with ECOG performance status 0, 1 or 2.
You may not be if
Patient with Grade 3b (aggressive) FL or any histology other than FL grade 1, 2 or 3a
Patient who has previously received any prior therapy for lymphoma
Patient with evidence of any uncontrolled, active infection (viral, bacterial or fungal).
Patient with any malignancy within 5 years prior to date of randomization, with the exception of adequately treated in situ carcinoma of the cervix uteri, basal or squamous cell carcinoma or non-melanomatous skin cancer.
